» Authors » Zhicheng Yao

Zhicheng Yao

Explore the profile of Zhicheng Yao including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 77
Citations 986
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu F, Xia Q, Chen B, Wang R, Zhao X, Zhang Z, et al.
Cell Death Differ . 2025 Mar; PMID: 40055579
The ubiquitination of histone H2A/H2AX, catalyzed by RNF8/RNF168, is a crucial step in the repair of DNA double-strand breaks (DSBs), playing a significant role in transmitting and amplifying DNA damage...
2.
Na L, Song X, Luo P, Su J, Yao Z
Front Bioeng Biotechnol . 2025 Feb; 12:1456704. PMID: 39911816
Cerebrovascular imaging is essential for the diagnosis, treatment, and prognosis of cerebrovascular disease, including stroke, aneurysms, and vascular malformations. Conventional imaging techniques such as MRI, CT, DSA and ultrasound have...
3.
Chen B, Xu F, Wang R, Zhao X, Yao Z, Zhang J, et al.
Oncogene . 2025 Feb; PMID: 39900724
RPA2, a key component of the RPA complex, is essential for single-stranded DNA (ssDNA) binding and DNA repair. However, the regulation of RPA2-ssDNA interaction and the recruitment of repair proteins...
4.
Yuan F, Tang Y, Liang H, Cao M, Ren Y, Li Y, et al.
Genomics . 2025 Jan; 117(2):110999. PMID: 39863187
Introduction: Resistance to lenvatinib limits the effectiveness of the targeted treatments for HCC. However, the exact mechanism behind this resistance remains elusive. Current research suggests that circular RNA (circRNA) is...
5.
Yang S, Wang R, Liu L, Xu F, Zhao X, Yao Z, et al.
Cell Death Discov . 2024 Dec; 10(1):496. PMID: 39695160
Ribonucleotide reductase M1 (RRM1), the catalytic subunit of ribonucleotide reductase, plays a pivotal role in converting ribonucleotides (NTP) into deoxyribonucleotides (dNTP), essential for DNA replication and repair. Elevated RRM1 expression...
6.
Li L, Yao Z, Salimian K, Kong J, Zaheer A, Parian A, et al.
Adv Healthc Mater . 2024 Sep; :e2402292. PMID: 39240055
Perianal fistulas represent a common, aggressive, and disabling complication of Crohn's disease (CD). Despite recent drug developments, novel surgical interventions as well as multidisciplinary treatment approaches, the outcome is dismal,...
7.
Su X, Li Y, Ren Y, Cao M, Yang G, Luo J, et al.
Biomed Pharmacother . 2024 Jun; 176:116902. PMID: 38870626
Drug resistance in hepatocellular carcinoma has posed significant obstacles to effective treatment. Recent evidence indicates that, in addition to traditional gene mutations, epigenetic recoding plays a crucial role in HCC...
8.
Qu H, Song X, Song Z, Jiang X, Gao X, Bai L, et al.
Cancer Cell Int . 2024 Jun; 24(1):202. PMID: 38849901
No abstract available.
9.
Ren Y, Li Y, Cao M, Tang Y, Yuan F, Yang G, et al.
Chin J Cancer Res . 2024 May; 36(2):114-123. PMID: 38751440
Objective: Unresectable hepatocellular carcinoma (uHCC) continues to pose effective treatment options. The objective of this study was to assess the efficacy and safety of combining low-dose cyclophosphamide with lenvatinib, pembrolizumab...
10.
Ouyang J, Sun L, She Z, Li R, Zeng F, Yao Z, et al.
ACS Appl Mater Interfaces . 2024 Apr; PMID: 38593207
Wounds infected with bacteria, if left untreated, have the potential to escalate into life-threatening conditions, such as sepsis, which is characterized by widespread inflammation and organ damage. A comprehensive approach...